Neutrophil response
| UPN . | Pretherapy ANC, mean . | Steady-state ANC, mean . | Response . |
|---|---|---|---|
| 21 | 0.4 | 1.8 | CR |
| 22 | N/A | 2.7 | N/A |
| 23 | 1.3 | 5.13 | N/A |
| 24 | 0.27 | 1.44 | CR |
| 25 | 0.68 | 2.20 | CR |
| 26 | 0.13 | 1.83 | CR |
| 27 | 0.27 | 0.89 | PR |
| 28 | 0.64 | 2.15 | CR |
| 31 | 0.34 | 3.11 | N/A |
| 32 | 0.58 | 1.82 | CR |
| 33 | 0.30 | 2.22 | CR |
| 34 | 0.14 | 3.0 | CR |
| 35 | 0.44 | 3.36 | CR |
| mean = 0.46 | mean = 2.43 | P < .01 |
| UPN . | Pretherapy ANC, mean . | Steady-state ANC, mean . | Response . |
|---|---|---|---|
| 21 | 0.4 | 1.8 | CR |
| 22 | N/A | 2.7 | N/A |
| 23 | 1.3 | 5.13 | N/A |
| 24 | 0.27 | 1.44 | CR |
| 25 | 0.68 | 2.20 | CR |
| 26 | 0.13 | 1.83 | CR |
| 27 | 0.27 | 0.89 | PR |
| 28 | 0.64 | 2.15 | CR |
| 31 | 0.34 | 3.11 | N/A |
| 32 | 0.58 | 1.82 | CR |
| 33 | 0.30 | 2.22 | CR |
| 34 | 0.14 | 3.0 | CR |
| 35 | 0.44 | 3.36 | CR |
| mean = 0.46 | mean = 2.43 | P < .01 |
Pretherapy ANC indicates the mean of all available ANCs for each patient prior to initiation of cytokine therapy. The steady-state ANC indicates the mean of all available ANCs for each patient during maintenance phase. CR is the mean ANC > 1.0 × 109 cells/L, and PR is the mean ANC between 0.8 and 1.0 × 109 cells/L. The P value was obtained by the t test for paired data.